NEONAID - Neonatal Online Neuro-Analysis for Interpretation and Decision-support - Bringing automated neonatal monitoring to the bedside
From 01-09-2024 to 31-08-2026
Description
Even though huge progress has been made in order to reduce the mortality of prematurely born infants, the risk for adverse health outcome and neurodevelopmental disability has increased. This, together with an increasing rate of premature births, represents a huge burden in our society. In order to reduce this burden and improve neonatal care, appropriate tools to early identify the neonates with higher risk of adverse outcomes should be developed. In the past, we have developed a variety of advanced algorithms that quantify EEG patterns and autoregulation which can support the identification of such neonates. These algorithms provide an automated, objective and interpretable analysis of the complex biomedical signals, but so far have only been validated offline on carefully selected recordings. The current project aims at making those algorithms more robust to variations in signal quality observed on the ward, as well as providing reliability scores for their output so that they can be routinely used at the bedside. Additionally, we aim to bring these algorithms to the bedside in the NICU with MDR approval in order to demonstrate the clinical impact. In parallel, the project will evaluate valorisation strategies such as tele-monitoring for neonatal care units.
Team
- Maarten De Vos, Coordinator
Financing
Funding: KU Leuven - Internal Funding KU Leuven
Program/Grant Type: C3 - KU Leuven Category 3 Funding
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.